Keenan Greg 4

What Happened Greg Keenan, SVP and Chief Medical Officer of Aurinia Pharmaceuticals (AUPH), had 11,552 shares withheld to satisfy tax withholding upon the vesting of restricted stock units. The shares were valued at $14.53 each, for a total of $167,851. This transaction is a tax-withholding disposal tied to RSU vesting—not an open-market sale or purchase.

Key Details

• Transaction date: 2026-02-02
• Price per share: $14.53; Total value: $167,851
• Transaction type/code: F — shares withheld to satisfy tax withholding on vested RSUs
• Footnote: F1 — Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units
• Shares owned after transaction: Not specified in the excerpt of the filing
• Filing timeliness: Report filed 2026-02-03 for the 2026-02-02 transaction (appears timely)

Context Tax-withholding dispositions are routine administrative transactions that occur when RSUs vest; they do not necessarily signal the insider’s view on the company’s prospects. This was not an open-market sale or a purchase.